Table 1 Baseline Characteristics
All Patients N = 220 | Angiography Cohort N = 42 | |
|---|---|---|
Age at transplant, years | 55 ± 11 | 60 ± 8 |
Age > 60 | 71 (32.3%) | 21 (50.0%) |
Female sex | 85 (38.6%) | 17 (40.5%) |
Race | ||
Black | 54 (24.5%) | 13 (31%) |
White | 117 (53.2%) | 21 (50.0%) |
Hispanic | 15 (6.8%) | 3 (7.1%) |
BMI, kg/m2 | 28 ± 8 | 31 ± 7 |
Etiology of liver disease | ||
Hepatitis C | 101 (40.6%) | 16 (38.1%) |
Alcoholic | 51 (20.5%) | 5 (11.9%) |
Non-Alcoholic Steatohepatitis | 22 (8.8%) | 10 (23.8%) |
Autoimmune | 22 (8.8%) | 2 (4.8%) |
Hyperlipidemia | 29 (13.2%) | 11 (26.2%) |
Hypertension | 87 (39.5%) | 20 (47.6%) |
Diabetes Mellitus | 74 (33.6%) | 19 (45.2%) |
Tobacco Use | 27 (12.3%) | 7 (16.7%) |
Congestive Heart Failure | 8 (3.6%) | 5 (11.9%) |
Ejection Fraction | 62 ± 8% | 64 ± 11 |
Left ventricular hypertrophy | 14 (6.4%) | 3 (7.1%) |
Cerebrovascular disease (CVA/TIA) | 13 (5.9%) | 6 (14.3%) |
Peripheral Arterial Disease | 14 (6.4%) | 6 (14.3%) |
Known CAD | 29 (13.2%) | 15 (35.7%) |
History of MI | 13 (5.9%) | 8 (19.0%) |
History of PCI | 17 (7.7%) | 11 (26.2%) |
History of CABG | 7 (3.2%) | 4 (9.5%) |
MELD Score, mean ± SD | 21 ± 11 | 21 ± 12 |
AHA/ACCF risk factors, mean ± SD | 2.3 ± 1.7 | 3.0 ± 1.8 |
AHA/ACCF risk factors, n | ||
0–1 | 77 (35%) | 10 (23.8%) |
2 | 54 (24.5%) | 11 (26.2%) |
3 | 38 (17.3%) | 5 (11.9%) |
4 | 28 (12.7%) | 6 (14.3%) |
5 or more | 23 (10.5%) | 10 (23.8%) |